IL-1β and iNOS can drive the asthmatic comorbidities and decrease of lung function in perennial allergic rhinitis children.

Myung Woul HanSong Hee KimInbo OhYang Ho KimJiho Lee

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2024)

This study suggests that IL-1β and iNOS can be biomarkers in the progression of PAR and asthma and decreased lung function, suggesting potential targets for early intervention and treatment.

Keyphrases

lung function
allergic rhinitis
chronic obstructive pulmonary disease
cystic fibrosis
air pollution
randomized controlled trial
nitric oxide synthase
young adults
nitric oxide
risk assessment
human health
replacement therapy